Carl Zeiss Meditec reports strong sales growth but lower margins for Q1
Carl Zeiss Meditec revenues increased by 14.6 percent year-on-year in Q1 2022/23 to €470.3 million, or by 12.1 percent in constant currencies, in spite of ongoing supply chain issues for both its business units. At constant exchange rates and compared with Q1 2021/22, sales in the Ophthalmology division went up ...
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.